Total Payments
$20,824
2024 Payments
$3,001
Companies
79
Transactions
1,002
Medicare Patients
3,426
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$19,329 (92.8%)
Research$703.81 (3.4%)
Travel$427.17 (2.1%)
Education$302.35 (1.5%)
Other$61.57 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,329 | 987 | 92.8% |
| Unspecified | $703.81 | 1 | 3.4% |
| Travel and Lodging | $427.17 | 3 | 2.1% |
| Education | $302.35 | 6 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61.57 | 5 | 0.3% |
Payments by Type
General
$20,120
1,001 transactions
Research
$703.81
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,165 | 192 | $0 (2024) |
| Allergan, Inc. | $2,244 | 93 | $0 (2022) |
| ABBVIE INC. | $2,124 | 103 | $0 (2024) |
| GENZYME CORPORATION | $1,916 | 64 | $0 (2022) |
| Genentech USA, Inc. | $1,341 | 73 | $0 (2024) |
| Biogen, Inc. | $963.05 | 47 | $0 (2024) |
| EMD Serono, Inc. | $802.11 | 47 | $0 (2024) |
| Novartis Pharma AG | $703.81 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $700.95 | 55 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $659.77 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,001 | 149 | ABBVIE INC. ($718.58) |
| 2023 | $2,908 | 155 | ABBVIE INC. ($927.67) |
| 2022 | $1,838 | 103 | ABBVIE INC. ($376.72) |
| 2021 | $2,284 | 87 | Novartis Pharma AG ($703.81) |
| 2020 | $1,681 | 82 | Allergan, Inc. ($539.98) |
| 2019 | $3,136 | 163 | Allergan Inc. ($576.21) |
| 2018 | $3,272 | 139 | Novartis Pharmaceuticals Corporation ($792.86) |
| 2017 | $2,703 | 124 | Sunovion Pharmaceuticals Inc. ($442.04) |
All Payment Transactions
1,002 individual payment records from CMS Open Payments — Page 2 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Neurology | ||||||
| 10/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Neurology | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Neurology | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Neurology | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $76.34 | General |
| Category: Rare Disease | ||||||
| 09/10/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immune | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Neurology | ||||||
| 08/29/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Genetic Disease | ||||||
| 08/27/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Neurology | ||||||
| 08/21/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Neurology | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: Neurology | ||||||
| 08/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $703.81 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 883 | 35,053 | $623,681 | $253,568 |
| 2022 | 21 | 857 | 41,859 | $1.7M | $561,508 |
| 2021 | 21 | 833 | 34,547 | $564,692 | $242,927 |
| 2020 | 22 | 853 | 39,595 | $1.7M | $509,611 |
Total Patients
3,426
Total Services
151,054
Medicare Billing
$1.6M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 45 | 33,908 | $305,172 | $159,865 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 236 | $37,760 | $19,728 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 119 | 150 | $34,500 | $18,108 | 52.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 182 | $33,670 | $10,664 | 31.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 54 | 85 | $28,900 | $5,889 | 20.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 18 | 56 | $21,000 | $5,361 | 25.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $15,200 | $5,083 | 33.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 48 | $13,440 | $4,540 | 33.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 29 | 29 | $37,700 | $3,531 | 9.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 37 | $8,325 | $3,146 | 37.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 11 | 28 | $10,528 | $2,755 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 45 | $5,400 | $2,664 | 49.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 49 | 79 | $16,590 | $2,492 | 15.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,250 | $2,160 | 41.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 28 | 28 | $25,200 | $2,140 | 8.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 18 | $8,496 | $1,633 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,275 | $1,522 | 35.6% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 11 | 11 | $7,700 | $850.09 | 11.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 16 | $2,880 | $674.40 | 23.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 14 | 14 | $980.00 | $411.58 | 42.0% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 13 | 13 | $715.00 | $349.68 | 48.9% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2022 | 11 | 6,900 | $1.2M | $323,909 | 27.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 39 | 33,852 | $304,668 | $153,426 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 229 | $36,640 | $19,293 | 52.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 87 | 101 | $34,730 | $12,303 | 35.4% |
About Dr. Craig Herrman, MD
Dr. Craig Herrman, MD is a Neurology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750385332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Herrman, MD has received a total of $20,824 in payments from pharmaceutical and medical device companies, with $3,001 received in 2024. These payments were reported across 1,002 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($19,329).
As a Medicare-enrolled provider, Herrman has provided services to 3,426 Medicare beneficiaries, totaling 151,054 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Indianapolis, IN
- Active Since 06/10/2005
- Last Updated 03/23/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750385332
Products in Payments
- BOTOX (Biological) $2,728
- KESIMPTA (Drug) $1,137
- ARZERRA (Drug) $1,086
- AUBAGIO (Drug) $925.69
- GILENYA (Drug) $915.11
- OCREVUS (Biological) $790.29
- APTIOM (Drug) $700.95
- TYSABRI (Biological) $646.22
- BOTOX THERAPEUTIC (Biological) $579.36
- LEMTRADA (Drug) $567.44
- UBRELVY (Drug) $512.36
- BRIUMVI (Drug) $501.96
- MAYZENT (Drug) $397.05
- Ocrevus (Biological) $364.49
- INGREZZA (Drug) $348.86
- QULIPTA (Drug) $336.64
- DISEASE STATE (Drug) $307.34
- SOLIRIS (Drug) $280.95
- Non-Covered Product (Drug) $236.75
- BAFIERTAM (Drug) $235.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Indianapolis
Kristi George, Md, MD
Neurology — Payments: $318,483
Neurology $318,483
Martin Farlow, Md, MD
Neurology — Payments: $291,677
Neurology $291,677
Cassandra Curtis, Md, MD
Neurology — Payments: $231,041
Neurology $231,041
Dr. Eric Siemers, M.d, M.D
Neurology — Payments: $128,503
Neurology $128,503
Liana Apostolova, Md, MD
Neurology — Payments: $94,479
Neurology $94,479
Bert Vargas, Md, MD
Neurology — Payments: $85,316
Neurology $85,316